| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/20/2003 | CA2459769A1 Igf-1 as feline vaccine adjuvant, in particular against feline retroviruses |
| 03/20/2003 | CA2459731A1 Genetic analysis of biological samples in arrayed expanded representations of their nucleic acids |
| 03/20/2003 | CA2459586A1 Bacterial cells and vaccines comprising three or more colisurface antigens |
| 03/20/2003 | CA2459560A1 Methods of kidney transplantation utilizing developing nephric tissue |
| 03/20/2003 | CA2459426A1 Human immunodeficiency virus envelope glycoprotein mutants and uses thereof |
| 03/20/2003 | CA2459367A1 Methods for construction and screening of libraries of chemokine variants |
| 03/20/2003 | CA2459323A1 G-protein coupled receptors |
| 03/20/2003 | CA2459318A1 Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer |
| 03/20/2003 | CA2459307A1 Compositions comprising mixtures of therapeutic proteins and methods of producing the same |
| 03/20/2003 | CA2459202A1 Adipose-derived stem cells and lattices |
| 03/20/2003 | CA2458543A1 Compositions and methods for treatment of cancer |
| 03/20/2003 | CA2458047A1 Compositions and methods of use of targeting peptides against placenta and adipose tissues |
| 03/20/2003 | CA2457441A1 Infectious and attenuated bovine viral diarrhea virus clone; methods for their production and use |
| 03/20/2003 | CA2457282A1 Method for expression of small antiviral rna molecules within a cell |
| 03/20/2003 | CA2455990A1 Methods for diagnosing and treating diseases and conditions associated with protein kinase c.lambda. |
| 03/20/2003 | CA2454992A1 Adenoviral vector and related system and methods of making and use |
| 03/20/2003 | CA2451454A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 03/20/2003 | CA2451254A1 Novel proteins and nucleic acids encoding same |
| 03/20/2003 | CA2436341A1 Impartment of virus-resistance with the use of plant protein binding to plant virus transport protein |
| 03/19/2003 | WO2002027003A1 Transgenic plants which produce isomalt |
| 03/19/2003 | EP1293779A2 Biosensor surface |
| 03/19/2003 | EP1293573A2 Process for producing a marker-vaccine against a mammalian virus |
| 03/19/2003 | EP1293572A1 Method of altering plant secondary metobolite biosynthesis in plant cells |
| 03/19/2003 | EP1293571A2 Process for immobilizing enzymes to the cell wall of a microbial cell by producing a fusion protein |
| 03/19/2003 | EP1293570A2 Application of aprataxin gene to diagnosis and treatment for early-onset spinocerebellar ataxia (EAOH) |
| 03/19/2003 | EP1293569A2 Full-length cDNAs |
| 03/19/2003 | EP1293568A1 Novel protein and dna thereof |
| 03/19/2003 | EP1293567A1 Ligand to gpr8 and dna thereof |
| 03/19/2003 | EP1293566A1 A soluble toll-like receptor |
| 03/19/2003 | EP1293565A2 Mammalian telomerase RNA component |
| 03/19/2003 | EP1293564A1 Expression vector enabling screening of cells with high expression of recombinant protein, transformant with high expression of recombinant protein and utilization thereof |
| 03/19/2003 | EP1293563A1 Inhibition of apoptosis by the expression of antisense rna of caspase-3 |
| 03/19/2003 | EP1293562A1 Fungal glyoxal oxidases |
| 03/19/2003 | EP1293560A2 Methods for producing L-lysine and L-glutamic acid by fermentation |
| 03/19/2003 | EP1293559A1 Gas driven gene delivery instrument |
| 03/19/2003 | EP1293514A1 Multimeric single chain tandem Fv-antibodies |
| 03/19/2003 | EP1293513A2 A recombinant human factor VIII derivative |
| 03/19/2003 | EP1293512A2 DNA encoding the baboon and cynomolgus macaque prostaglandin E2 receptor EP4 subtype |
| 03/19/2003 | EP1293511A1 Canine liver cell growth factor |
| 03/19/2003 | EP1293510A1 Novel polypeptide and its dna |
| 03/19/2003 | EP1293144A2 Plate-shaped holder housing for daily use and/or consumer articles |
| 03/19/2003 | EP1292830A2 Method for identifying insulin mimics or antagonists |
| 03/19/2003 | EP1292827A1 T2r taste receptors and genes encoding same |
| 03/19/2003 | EP1292712A1 Means and methods for monitoring antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids |
| 03/19/2003 | EP1292710A2 Matrix screening method |
| 03/19/2003 | EP1292709A1 Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds |
| 03/19/2003 | EP1292706A2 Method of identifying ginko biloba in a plant extract by gene profiling |
| 03/19/2003 | EP1292705A2 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human bone marrow |
| 03/19/2003 | EP1292704A2 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human placenta |
| 03/19/2003 | EP1292697A2 Method for preparing a physiologically active il-18 polypeptide |
| 03/19/2003 | EP1292695A2 Gene-regulating conjugates |
| 03/19/2003 | EP1292694A2 A recombinant non-replicating virus expressing gm-csf and uses thereof to enhance immune responses |
| 03/19/2003 | EP1292693A2 Grain processing method and transgenic plants useful therein |
| 03/19/2003 | EP1292692A2 Hero resistance gene conferring resistance to nematodes |
| 03/19/2003 | EP1292690A2 Plant-signalling ligand like proteins |
| 03/19/2003 | EP1292689A1 Regulated gene expression in yeast and methods of use |
| 03/19/2003 | EP1292688A2 Promoters for regulated gene expression |
| 03/19/2003 | EP1292687A2 Regulated antigen delivery system (rads) involving bacteria |
| 03/19/2003 | EP1292686A1 Gene expression cassette and its use |
| 03/19/2003 | EP1292685A2 Human lyases |
| 03/19/2003 | EP1292684A2 Proteases |
| 03/19/2003 | EP1292683A2 Secreted redox proteins |
| 03/19/2003 | EP1292682A2 Method for the production of p-hydroxybenzoate in species of pseudomonas and agrobacterium |
| 03/19/2003 | EP1292681A1 Antigenic polypeptides |
| 03/19/2003 | EP1292680A2 Agonist anti-trk-c monoclonal antibodies |
| 03/19/2003 | EP1292679A1 A g-protein coupled receptor |
| 03/19/2003 | EP1292678A2 G-protein coupled receptors |
| 03/19/2003 | EP1292677A2 Human hm74-like g protein coupled receptor |
| 03/19/2003 | EP1292676A1 Mutation associated with epilepsy |
| 03/19/2003 | EP1292675A2 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 03/19/2003 | EP1292674A2 Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate |
| 03/19/2003 | EP1292668A2 Gene disruption methodologies in fungi for drug target discovery |
| 03/19/2003 | EP1292667A2 Identification and use of molecular markers indicating cellular reprogramming |
| 03/19/2003 | EP1292620A2 Nuclear hormone receptor |
| 03/19/2003 | EP1292619A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 03/19/2003 | EP1292617A1 Novel compounds |
| 03/19/2003 | EP1292616A2 Nucleic acids encoding a regulator of g protein signaling, rgs18, and uses thereof |
| 03/19/2003 | EP1292615A2 Modified morbillivirus v proteins |
| 03/19/2003 | EP1292614A2 Nucleotide sequence of influenza a/udorn/72 (h3n2) genome |
| 03/19/2003 | EP1292613A2 Chimeric gfp-aequorin as bioluminescent ca?++ reporters at the single cell level |
| 03/19/2003 | EP1292606A2 Positively-charged peptide nucleic acid analogs with improved properties |
| 03/19/2003 | EP1292605A2 Antisense modulation of inhibitor of dna binding-1 expression |
| 03/19/2003 | EP1292340A1 Transfection system |
| 03/19/2003 | EP1292331A2 Immunostimulatory rna/dna hybrid molecules |
| 03/19/2003 | EP1292329A1 Manipulation of negative stranded rna viruses by rearrangement of their genes and uses thereof |
| 03/19/2003 | EP1292326A2 Recombinant human cln2 protein and methods of its production and use |
| 03/19/2003 | EP1292323A1 Inhibition of smad3 to prevent fibrosis and improve wound healing |
| 03/19/2003 | EP1292289A2 Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers |
| 03/19/2003 | EP1292285A1 Delivery systems for bioactive agents |
| 03/19/2003 | EP1292284A2 Encapsulation of polynucleotides and drugs into targeted liposomes |
| 03/19/2003 | EP1292187A2 Transgenic animal model of neurodegenerative disorders |
| 03/19/2003 | EP1292186A1 Animal and cell models for type ii diabetes and their use |
| 03/19/2003 | EP1203093A4 2'-fluoropyrimidine anti-calf intestinal phosphatase nucleic acid ligands |
| 03/19/2003 | EP1096998B1 Method and device for preparing samples for detecting a nucleotide sequence |
| 03/19/2003 | EP1082344B1 Glycoproteins having lipid mobilising properties and therapeutic applications thereof |
| 03/19/2003 | EP1034268A4 G-protein coupled receptors and uses therefor |
| 03/19/2003 | EP0946286B1 Chemical amplification for the synthesis of patterned arrays |
| 03/19/2003 | EP0937156B1 Preparation of d-amino acids by direct fermentative means |
| 03/19/2003 | EP0910409A4 Recombinant constructs encoding t cell receptors specific for human hla-restricted tumor antigens |
| 03/19/2003 | EP0896631B1 Method for simultaneous detection of multiple fluorophores for in situ hybridization |